Get started
Author

Subarnarekha Chatterji

ORCID: 0000-0002-8980-4982
Observed ORCID: 0000-0002-8980-4982
OpenAlex ID: A5055566069
Defining genomic, transcriptomic, proteomic, epigenetic, and phenotypic biomarkers with prognostic capability in male breast cancer: a systematic review
2023 · Subarnarekha Chatterji, Emma Krzoska, et al. · The Lancet Oncology · 35
Analysis of the Clinical Advancements for BRCA-Related Malignancies Highlights the Lack of Treatment Evidence for BRCA-Positive Male Breast Cancer
2022 · Dylan P. McClurg, Gordan Urquhart, et al. · Cancers · 13
PDF
Prediction models for hormone receptor status in female breast cancer do not extend to males: further evidence of sex-based disparity in breast cancer
2023 · Subarnarekha Chatterji, Jan Moritz Niehues, et al. · npj Breast Cancer · 12
PDF
Exploring the One Health Paradigm in Male Breast Cancer
2024 · Kirsty Luo-Yng Tay, George Cowan, et al. · Journal of Mammary Gland Biology and Neoplasia · 5
PDF
Correlation of GSTP1 Polymorphism with Severity of Prostate Cancer in an Eastern Indian Population
2019 · Suparna Roy, Anindya Dasgupta, et al. · Journal of Advances in Medicine and Medical Research · 2
Oestrogen receptor phosphorylation profiles and in silico PAM50 subtyping reflect sexual dimorphism in breast cancer
2026 · Subarnarekha Chatterji, Aimee Diack, et al. · The Journal of Pathology Clinical Research · 1
The multifaceted role of the potassium channel KCNK1 in the early detection and prognostication of high-grade serous cancer
2026 · Subarnarekha Chatterji, Elaine Craig, et al. · Journal of Ovarian Research
Emerging Research in Medical Sciences Vol. 1
2019 · P. I. Opara, E. A. Alinnor, et al. · Book Publisher International (a part of SCIENCEDOMAIN International)
Works count: 8
Citation count: 68
H-index: 4
I10-index: 3
Year
Topic
Type